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ifferences in Cardiac
emodeling Associated
ith Race
mplications for Pre-Participation
creening and the Unfavorable
ituation of Black Athletes*
ntonio Pelliccia, MD
ome, Italy
he unexpected, tragic, and highly publicized sudden
eaths of top-level athletes reported by the media periodi-
ally inflate the debate regarding the most appropriate
trategy for identifying individuals at risk and preventing
hese catastrophes (1–3). Indeed, there is a growing percep-
ion in the lay public and medical community that the
revalence of athletic field deaths is larger than previously
elieved and, although not epidemic, there are innumerable
vents terminating the lives of young athletes that pass
ncovered by media.
See pages 2250 and 2256
Pre-participation cardiovascular screening, routinely
ncluding 12-lead electrocardiography (ECG), has been
n practice in Italy in the last 25 years (4), and has been
hown to reduce mortality in a large population of young
ompetitive athletes, owing to timely identification
largely with ECG) of individuals with clinically silent
ardiomyopathies and their subsequent disqualification
rom competitive sport (5). The inclusion of ECG into
re-participation screening programs has been supported
y the European Society of Cardiology and the Medical
ommission of the International Olympic Committee
6,7). Recently, the statement that ECG should be
ncluded in the pre-participation screening of collegiate
nd high school athletes in the U.S. has been endorsed in
highly publicized scientific debate (8).
However, the implementation of the 12-lead ECG into
re-participation screening is a still-debated clinical issue
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.o
From the Institute of Sports Medicine and Science, Italian National Olympic
ommittee, Rome, Italy.nd raises justified concern, owing to the expected large
roportion of abnormal patterns in young trained individ-
als (9), which would require additional diagnostic testing
o confirm (or exclude) the presence of underlying cardio-
ascular disease (10,11).
In this perspective, the paper by Magalski et al. (12) in
his issue of the Journal, deserves particular interest. The
uthors (12) have investigated the potential impact of race
n ECG changes in young trained athletes. In a large cohort
f 1,959 collegiate football players (of whom 67% were
lack), the authors found a substantially larger proportion of
bnormal ECGs in black compared with white athletes
30% vs. 13%; p  0.001). In this regard, it is worth noting
hat the prevalence of ECG abnormalities in white U.S.
thletes is similar to that found in white European athletes
i.e., 11.8% in a large cohort of Italian young athletes) (13)
nd confirms that only a relatively small proportion of young
hite subjects show ECG changes that raise clinical con-
ern for underlying pathologic conditions.
Indeed, Magalski et al. (12) described that the most
bnormal patterns, including markedly increased R/S wave
oltages, diffuse T-wave inversion, and deep Q waves
defined as distinctly abnormal ECGs), suggesting the
resence of cardiac disease, were found in 5.8% of blacks
ersus only 1.8% of whites (p  0.005). These striking
atterns were 10 times more common in blacks than in
hites and explained most of the differences associated with
ace (12). In conclusion, black race was the only indepen-
ent predictor for all of the abnormal ECGs (relative risk
RR] 2.03) and, specifically, for the distinctly abnormal
CGs (RR 2.59), after adjustment for all other variables.
In addition, the presence of abnormal ECGs was some-
ow related to football player position, with wide receivers,
efensive backs, and running backs showing 2-fold more
bnormalities compared with other players. The relation-
hip of ECG pattern to type of training and endurance
apacity is consistent with the results of a previous investi-
ation in a large cohort of Italian competitive athletes and
uggests that extent of physiologic cardiac remodeling may
e, at least in part, responsible for the alterations in the
CG (9).
Unfortunately, the authors were not able to collect ECGs
rom all individuals presenting with abnormal ECGs, and,
herefore, the proportion of false-positive results in black
ersus white athletes was not defined. However, in all
thletes in whom echocardiography was performed no
ardiac disease was found, raising suspicion that a majority
f abnormal ECGs might represent false-positive results.
Also in this issue of the Journal, Basavarajaiah et al. (14)
onducted a comparative ECG study of cardiac dimensions
n black versus white young athletes. Black athletes showed
reater LV wall thickness and mass but similar cavity size
ompared with white athletes matched for age, body size,
nd level of blood pressure. In addition, a larger proportion
f black athletes (18% vs. 4%) showed LV wall thickness
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Editorial Comment June 10, 2008:2263–5ncreased above normal values (i.e., 12 mm), including an
mportant subset of 3% showing substantial wall thickening
15 mm), suggesting the presence of hypertrophic cardio-
yopathy (HCM).
As a corollary finding, Basavarajaiah et al. (14) described
hat ECG changes suggestive of LV hypertrophy (Sokolow-
yon voltage criteria) were much more common in black
thletes with echocardiographic evidence of LV hypertro-
hy (i.e., 68% vs. 40% of white athletes; p  0.001).
oreover, certain ECG abnormalities that are consistently
ound in HCM, such as deep T-wave inversion in precordial
eads, occurred in a substantial minority of black (12%) but
n no white athletes (14).
A new valuable insight provided by the Basavarajaiah
t al. (14) investigation was the different predisposition for
V hypertrophy with respect to the ancestral origin of black
thletes (i.e., the Caribbean, West Africa, or East Africa).
he LV hypertrophy was predominately seen in individuals
riginating from the Caribbean or West Africa (20%) and
as unusual in individuals coming from East Africa (7%).
Therefore, it seems that ethnicity (through a combination
f genetic, endocrine, and other still unknown mechanisms)
ay be responsible in black athletes (and mostly in those
rom West Africa or Caribbean) for a disproportionate
ardiac remodeling, characterized by a greater LV wall
hickening (but equivalent cavity size), than in white ath-
etes. Consistently, cardiac remodeling is associated with a
arger prevalence of ECG alterations suggestive of LV
ypertrophy in West African or Afro-Caribbean compared
ith white athletes.
The novel data provided by these 2 studies are of
articular clinical interest for their implications in the
ardiovascular screening of young competitive athletes. It
ppears that young black individuals are in a particularly
nfavorable situation when exposed to pre-participation
creening programs. Black athletes have a disproportion-
tely higher probability of showing abnormal ECG patterns
ompared with their white teammates and, specifically, of
resenting those alterations that unavoidably raise question
f underlying HCM. Consequently, echocardiography or
ther imaging testing (i.e., cardiac magnetic resonance) will
e needed to solve the ambiguity of abnormal ECG patterns
n a larger proportion of black compared with white indi-
iduals, multiplying the occurrence of false-positive results
nd thus the probability for black athletes to be disqualified
rom competitive sports.
Therefore, the Magalski et al. (12) and Basavarajaiah
t al. (14) studies have relevance to the contemporary
cientific debate regarding the feasibility and limitation of
re-participation screening programs in young athletes
8,10). The data suggest the impracticality of cardiovascular
creening programs in large populations of black athletes,
ot only for the expected large proportion of ECG abnor-
alities and the disproportionate request for imaging and
ther testing in selected cases, but also for the limited access
o medical services of a sizeable proportion of the blackopulation, which includes several millions of uninsured
oung individuals.
However, considerating that sudden cardiac deaths dis-
roportionately affect young black athletes (40% of all
thletic field deaths) (2), we believe that scientific associa-
ions should pursue all efforts to reduce the burden of these
dverse events by supporting the most cost-efficient strategy
o timely identify all young individuals at risk. In this
erspective, the studies by Magalski et al. (12) and Basa-
arajaiah et al. (14) are of particular clinical value in
djusting our biased knowledge of normality (derived from
revious investigations made in white subjects) by introduc-
ng the novelty of race-related appropriate standards for
nterpretation of ECG pattern and physiologic cardiac
emodeling in athletes, therefore diminishing the risk for
lack athletes to be deprived of the many opportunities and
enefits (including economic) derived from an athletic
ifestyle.
In the near future, efforts should be made to better
nderstand the mechanisms and limits of different cardiac
esponse to athletic conditioning in athletes, and new
tandards should be defined with consideration of ethnicity
n addition to age, gender, and sport. These investigations
re particularly needed in countries with heterogeneous
opulations to offer equal opportunities to the different
egments of those societies. In this perspective, implemen-
ation of large-scale screening programs with 12-lead ECG
n athlete populations of different ethnic origins represent
he way to increase our knowledge, with ensuing applica-
ions in the customary clinical practice (15).
eprint requests and correspondence: Dr. Antonio Pelliccia,
nstitute of Sports Medicine and Science, Largo Piero Gabrielli, 1,
0197 Rome, Italy. E-mail: ant.pelliccia@libero.it.
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